The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options
Abstract
Summary: Secondary hyperparathyroidism (SHPT) is a challenge frequently encountered in the management of patients with chronic kidney disease (CKD). Downregulation of the parathyroid vitamin D and calcium-sensing receptors represent critical steps that lead to abnormalities in mineral metabolism: high phosphate, low calcium, and vitamin D deficiency. These imbalances result in parathyroid hyperplasia and contribute to vascular calcification. New studies have established a central role for fibroblast growth factor 23 (FGF-23) in the regulation of phosphate-vitamin D homeostasis. FGF-23 concentration increases in CKD and contributes to SHPT. Achieving current targets for the key mineral parameters in the management of SHPT set by the Kidney Disease Improving Global Outcomes (KDIGO) guidelines can be challenging. This review summarizes the current understanding and evidence supporting strategies for SHPT treatment in CKD patients. Treatment should include a combination of dietary phosphorus restriction, phosphate binders, vitamin D sterols, and calcimimetics. Parathyroidectomy is effective in suitable candidates refractory to medical therapy and the standard against which new approaches should be measured. Future strategies may focus on the stimulation of apoptotic activity of hyperplastic parathyroid cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Massry, S. G., Coburn, J. W., Chertow, G. M., Hruska, K. A., Langman, C. B., Malluche, H. H., Martin, K. J., McCann, L. M., McCarthy, J. T., Moe, S. M., et al. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2,527
Self-citationMacLeod, A. M. (2009) · Kidney International · Cited by 2,218
Bone metabolism and disease in chronic kidney disease
Eknoyan, G., Levin, A., & Levin, N. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00905-3 · Cited by 1,286
The parathyroid is a target organ for FGF23 in rats
Ben-Dov, I. Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R., Kuro-o, M., Mohammadi, M., Sirkis, R., Naveh-Many, T., & Silver, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32409 · Cited by 951
Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
Teng, M., Wolf, M., Lowrie, E., Ofsthun, N., Lazarus, J. M., & Thadhani, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022536 · Cited by 927
Block, G. A., Raggi, P., Bellasi, A., Kooienga, L., & Spiegel, D. M. (2007) · Kidney International · doi:10.1038/sj.ki.5002059 · Cited by 796
Activated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study
Teng, M., Wolf, M., Ofsthun, M. N., Lazarus, J. M., Hernán, M. A., Camargo, C. A., & Thadhani, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070573 · Cited by 782
Fukuda, N., Tanaka, H., Tominaga, Y., Fukagawa, M., Kurokawa, K., & Seino, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116720 · Cited by 596
Mechanisms of Vascular Calcification in Chronic Kidney Disease
Moe, S. M., & Chen, N. X. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007080854 · Cited by 579
Raggi, P., Chertow, G. M., Torres, P. U., Csiky, B., Naso, A., Nossuli, K., Moustafa, M., Goodman, W. G., Lopez, N., Downey, G., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq725 · Cited by 574
Xiang, W., Kong, J., Chen, S., Cao, L.-P., Qiao, G., Zheng, W., Liu, W., Li, X., Gardner, D. G., & Li, Y. C. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00224.2004 · Cited by 570
Li, Y. C., Amling, M., Pirro, A. E., Priemel, M., Meuse, J., Baron, R., Delling, G., & Demay, M. B. (1998) · Endocrinology · doi:10.1210/endo.139.10.6262 · Cited by 524
Pathophysiology of Vascular Calcification in Chronic Kidney Disease
Moe, S. M., & Chen, N. X. (2004) · Circulation Research · doi:10.1161/01.res.0000141775.67189.98 · Cited by 502
Parker, B. D., Schurgers, L. J., Brandenburg, V. M., Christenson, R. H., Vermeer, C., Ketteler, M., Shlipak, M. G., Whooley, M. A., & Ix, J. H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-10-201005180-00004 · Cited by 457
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
Sprague, S. M., Llach, F., Amdahl, M., Taccetta, C., & Batlle, D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00878.x · Cited by 392
Mortality risk among hemodialysis patients receiving different vitamin D analogs
Tentori, F., for the Medical Directors of Dialysis Clinic Inc., Hunt, W. C., Stidley, C. A., Rohrscheib, M. R., Bedrick, E. J., Meyer, K. B., Johnson, H. K., & Zager, P. G. (2006) · Kidney International · doi:10.1038/sj.ki.5001868 · Cited by 391
Zhou, C., Lu, F., Cao, K., Xu, D., Goltzman, D., & Miao, D. (2008) · Kidney International · doi:10.1038/ki.2008.101 · Cited by 391
Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl
Nemeth, E. F., Heaton, W. H., Miller, M., Fox, J., Balandrin, M. F., Van Wagenen, B. C., Colloton, M., Karbon, W., Scherrer, J., Shatzen, E., et al. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.057273 · Cited by 369
Pathogenesis of secondary hyperparathyroidism
Slatopolsky, E., Brown, A., & Dusso, A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07304.x · Cited by 309
Bleyer, A. J., Burke, S. K., Dillon, M., Garrett, B., Kant, K. S., Lynch, D., Rahman, S. N., Schoenfeld, P., Teitelbaum, I., Zeig, S., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70221-0 · Cited by 274
Komaba, H., Goto, S., Fujii, H., Hamada, Y., Kobayashi, A., Shibuya, K., Tominaga, Y., Otsuki, N., Nibu, K.-I., Nakagawa, K., et al. (2010) · Kidney International · doi:10.1038/ki.2009.414 · Cited by 267
1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia
Szabo, A., Merke, J., Beier, E., Mall, G., & Ritz, E. (1989) · Kidney International · doi:10.1038/ki.1989.89 · Cited by 255
Galitzer, H., Ben-Dov, I. Z., Silver, J., & Naveh-Many, T. (2010) · Kidney International · doi:10.1038/ki.2009.464 · Cited by 246
Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse
Simpson, R. U., Hershey, S. H., & Nibbelink, K. A. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.098 · Cited by 227
Nakanishi, S., Kazama, J. J., Nii-Kono, T., Omori, K., Yamashita, T., Fukumoto, S., Gejyo, F., Shigematsu, T., & Fukagawa, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00184.x · Cited by 209
Vitamin D and vascular calcification
Zittermann, A., Schleithoff, S. S., & Koerfer, R. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328011c6fc · Cited by 204
FGF23 Fails to Inhibit Uremic Parathyroid Glands
Canalejo, R., Canalejo, A., Martinez-Moreno, J. M., Rodriguez-Ortiz, M. E., Estepa, J. C., Mendoza, F. J., Munoz-Castaneda, J. R., Shalhoub, V., Almaden, Y., & Rodriguez, M. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009040427 · Cited by 195
Self-citationOral active vitamin D is associated with improved survival in hemodialysis patients
Naves-Díaz, M., Álvarez-Hernández, D., Passlick-Deetjen, J., Guinsburg, A., Marelli, C., Rodriguez-Puyol, D., & Cannata-Andía, J. B. (2008) · Kidney International · doi:10.1038/ki.2008.343 · Cited by 195
Goodman, W. G., & Quarles, L. D. (2008) · Kidney International · doi:10.1038/sj.ki.5002287 · Cited by 190
The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism
Rodriguez, M., Nemeth, E., & Martin, D. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00302.2004 · Cited by 181
Self-citationBerndt, T., Thomas, L. F., Craig, T. A., Sommer, S., Li, X., Bergstralh, E. J., & Kumar, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704446104 · Cited by 178
Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism
Colloton, M., Shatzen, E., Miller, G., Stehman-Breen, C., Wada, M., Lacey, D., & Martin, D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67103.x · Cited by 174
FGF23–parathyroid interaction: implications in chronic kidney disease
Komaba, H., & Fukagawa, M. (2010) · Kidney International · doi:10.1038/ki.2009.466 · Cited by 165
Postprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKD
Isakova, T., Gutierrez, O., Shah, A., Castaldo, L., Holmes, J., Lee, H., & Wolf, M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060673 · Cited by 160
Brown, A. J., Ritter, C. S., Finch, J. L., & Slatopolsky, E. A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00386.x · Cited by 158
NPS R-568 halts or reverses osteitis fibrosa in uremic rats
Wada, M., Ishii, H., FURUYA, Y., Fox, J., Nemeth, E. F., & Nagano, N. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00782.x · Cited by 152
Moe, S. M., & Drüeke, T. B. (2003) · American Journal of Nephrology · doi:10.1159/000073945 · Cited by 147
Lopez, J. I., Mendoza, F. J., Aguilera‐Tejero, E., Pérez, J., Guerrero, F., Martin, D., & Rodríguez, M. (2007) · Kidney International · doi:10.1038/sj.ki.5002675 · Cited by 137
Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients
Kazama, J. J., Sato, F., Omori, K., Hama, H., Yamamoto, S., 丸山弘樹, Narita, I., Gejyo, F., Yamashita, T., Fukumoto, S., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00178.x · Cited by 132
Intestinal Ca and phosphate transport: differential responses to vitamin D3 metabolites.
Walling, M. W. (1977) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1977.233.6.e488 · Cited by 118
Mizobuchi, M., Hatamura, I., Ogata, E., Saji, F., Uda, S., Shiizaki, K., Sakaguchi, T., Negi, S., Kinugasa, E., Koshikawa, S., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141016.20133.33 · Cited by 114
The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands
Rodriguez, M. E., Almadén, Y., Cañadillas, S., Canalejo, A., Siendones, E., Lopez, I., Aguilera‐Tejero, E., Martin, D., & Rodríguez, M. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00262.2006 · Cited by 105
Self-citationMeir, T., Levi, R., Lieben, L., Libutti, S. K., Carmeliet, G., Bouillon, R., Silver, J., & Naveh‐Many, T. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00360.2009 · Cited by 82
Molecular genetics of hyperparathyroid disease
Tominaga, Y., & Takagi, H. (1996) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199607000-00008 · Cited by 76
Etiology of Hypercalcemia in Hemodialysis Patients on Calcium Carbonate Therapy
Meric, F., Yap, P., & BIA, M. J. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80059-x · Cited by 61
Tilde]adillas, S. C., Canalejo, A., Santamaría, R., Rodríguez-Ortiz, M. E., Estepa, J. C., Martín‐Malo, A., Bravo, J. A., Ramos, B., Aguilera‐Tejero, E., Rodríguez, M., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080657 · Cited by 59
Lewin, E., Garfia, B., Luque, F., Rodríguez, M., & Ølgaard, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000024439.38838.03 · Cited by 59
Cañadillas, S., Canalejo, R., Rodríguez-Ortiz, M. E., Martinez-Moreno, J. M., Estepa, J. C., Zafra, R., Pérez, J., Muñoz-Castañeda, J. R., Canalejo, A., Rodríguez, M., et al. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00529.2009 · Cited by 34
Lafage‐Proust, M. (2010) · Kidney International · doi:10.1038/ki.2009.512 · Cited by 26
Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats
Lewin, E., Garfia, B., Almadén, Y., Rodríguez, M., & Ølgaard, K. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00056.x · Cited by 22
Galitzer, H., Lavi-Moshayoff, V., Nechama, M., Meir, T., Silver, J., & Naveh‐Many, T. (2009) · BMC Biology · doi:10.1186/1741-7007-7-17 · Cited by 19
Nakanishi, S. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg1012 · Cited by 18
Cited by
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects
Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., & Carmeliet, G. (2016) · Physiological Reviews · doi:10.1152/physrev.00014.2015 · Cited by 1,957
The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases
Hannan, F. M., Kallay, E., Chang, W., Brandi, M. L., & Thakker, R. V. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0115-0 · Cited by 394
Obesity and diabetes: An update
Verma, S., & Hussain, M. E. (2017) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2016.06.017 · Cited by 318
Parathyroidectomy in the Management of Secondary Hyperparathyroidism
Lau, W. L., Obi, Y., & Kalantar-Zadeh, K. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10390917 · Cited by 279
Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion
Centeno, P. P., Herberger, A., Mun, H.-C., Tu, C., Nemeth, E. F., Chang, W., Conigrave, A. D., & Ward, D. T. (2019) · Nature Communications · doi:10.1038/s41467-019-12399-9 · Cited by 254
Metadata
- Authors
- Cunningham, J., Locatelli, F., & Rodriguez, M.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2011-04
- Volume
- 6
- Issue
- 4
- Pages
- 913-921
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2136991956
- Cited by
- 646
- References
- 53
- FWCI
- 18.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.